In this webinar, Fedra Molaie-Holagh, Vice President of Regulatory Affairs, will discuss key considerations across the core drug development disciplines for developing a comprehensive NDA strategy and explore opportunities for streamlining the path from EoP2 to NDA submission.
Register for this webinar today to understand how new therapies can be developed by streamlining the path from EoP2 to NDA submission.
Join Fedra Molaie-Holagh, Vice President, Regulatory Affairs, Premier Consulting, for the live webinar on Tuesday, September 24, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit The Journey to Approval: Navigating the Road from EoP2 to NDA Submission.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
